Transcriptomic features of tumour-infiltrating CD4
CD4-Positive T-Lymphocytes
/ immunology
CD8-Positive T-Lymphocytes
/ immunology
Cell Plasticity
/ genetics
Cellular Reprogramming
/ genetics
Core Binding Factor Alpha 3 Subunit
/ metabolism
DNA-Binding Proteins
/ metabolism
Gene Expression Regulation, Neoplastic
/ immunology
Humans
Lymphocyte Activation
Lymphocytes, Tumor-Infiltrating
/ immunology
Melanoma
/ genetics
Receptors, Antigen, T-Cell, alpha-beta
/ metabolism
Skin Neoplasms
/ genetics
T-Lymphocyte Subsets
/ immunology
Transcription Factors
/ metabolism
Transcriptome
/ immunology
Tumor Microenvironment
/ genetics
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 04 2020
03 04 2020
Historique:
received:
18
12
2019
accepted:
17
03
2020
entrez:
5
4
2020
pubmed:
5
4
2020
medline:
15
12
2020
Statut:
epublish
Résumé
Peripheral CD4
Identifiants
pubmed: 32246006
doi: 10.1038/s41598-020-62664-x
pii: 10.1038/s41598-020-62664-x
pmc: PMC7125144
doi:
Substances chimiques
Core Binding Factor Alpha 3 Subunit
0
DNA-Binding Proteins
0
Receptors, Antigen, T-Cell, alpha-beta
0
Runx3 protein, human
0
Transcription Factors
0
ZBTB7B protein, human
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5900Références
Blue, M. L., Daley, J. F., Levine, H. & Schlossman, S. F. Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry. The Journal of Immunology 134, 2281–2286 (1985).
pubmed: 2982943
pmcid: 2982943
Nascimbeni, M., Shin, E.-C., Chiriboga, L., Kleiner, D. E. & Rehermann, B. Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions. Blood 104, 478–486 (2004).
doi: 10.1182/blood-2003-12-4395
pubmed: 15044252
pmcid: 15044252
Nascimbeni, M., Pol, S. & Saunier, B. Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C. PLoS ONE 6, e20145 (2011).
doi: 10.1371/journal.pone.0020145
pubmed: 21647449
pmcid: 21647449
Zloza, A. et al. Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface. Blood 114, 3841–3853 (2009).
doi: 10.1182/blood-2009-02-202481
pubmed: 19700667
pmcid: 19700667
Cortés, K. C. et al. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus. Journal of Viral Hepatitis 26, 942–950 (2019).
Quandt, D., Rothe, K., Scholz, R., Baerwald, C. W. & Wagner, U. Peripheral CD4CD8 double positive T cells with a distinct helper cytokine profile are increased in rheumatoid arthritis. PLoS ONE 9, e93293 (2014).
doi: 10.1371/journal.pone.0093293
pubmed: 24667579
pmcid: 24667579
Waschbisch, A. et al. Analysis of CD4+ CD8+ double-positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions. Clin. Exp. Immunol. 177, 404–411 (2014).
doi: 10.1111/cei.12345
pubmed: 24730443
pmcid: 24730443
Bagot, M. et al. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood 91, 4331–4341 (1998).
doi: 10.1182/blood.V91.11.4331
pubmed: 9596682
pmcid: 9596682
Desfrançois, J. et al. Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusions. Int. J. Cancer 125, 374–380 (2009).
doi: 10.1002/ijc.24366
pubmed: 19358272
pmcid: 19358272
Desfrançois, J. et al. Double Positive CD4CD8 αβ T Cells: A New Tumor-Reactive Population in Human Melanomas. PLOS ONE 5, e8437 (2010).
doi: 10.1371/journal.pone.0008437
pubmed: 20052413
pmcid: 20052413
Rahemtullah, A., Reichard, K. K., Preffer, F. I., Harris, N. L. & Hasserjian, R. P. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am. J. Clin. Pathol. 126, 805–814 (2006).
doi: 10.1309/Y8KD32QGRYFN1XQX
pubmed: 17050078
pmcid: 17050078
Sarrabayrouse, G. et al. Tumor-reactive CD4+ CD8αβ+ CD103+ αβT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers. Int. J. Cancer 128, 2923–2932 (2011).
doi: 10.1002/ijc.25640
pubmed: 20824715
pmcid: 20824715
Bohner, P. et al. Double Positive CD4+CD8+ T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization. Front. Immunol. 10 (2019).
Menard, L. C. et al. Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers. Front. Immunol. 9 (2018).
Parel, Y. & Chizzolini, C. CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev 3, 215–220 (2004).
doi: 10.1016/j.autrev.2003.09.001
pubmed: 15110234
pmcid: 15110234
Zloza, A. & Al-Harthi, L. Multiple populations of T lymphocytes are distinguished by the level of CD4 and CD8 coexpression and require individual consideration. J. Leukoc. Biol. 79, 4–6 (2006).
doi: 10.1189/jlb.0805455
Das, G. et al. An important regulatory role for CD4+CD8αα T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. PNAS 100, 5324–5329 (2003).
doi: 10.1073/pnas.0831037100
Sullivan, Y. B., Landay, A. L., Zack, J. A., Kitchen, S. G. & Al-Harthi, L. Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells. Immunology 103, 270–280 (2001).
doi: 10.1046/j.1365-2567.2001.01243.x
pubmed: 1783254
pmcid: 1783254
Kitchen, S. G. et al. Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor. Blood 99, 207–212 (2002).
doi: 10.1182/blood.V99.1.207
pubmed: 11756173
pmcid: 11756173
Parrot, T. et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology 5, e1250991 (2016).
doi: 10.1080/2162402X.2016.1250991
pubmed: 28123891
pmcid: 28123891
Takeuchi, A. et al. CRTAM determines the CD4+ cytotoxic T lymphocyte lineage. J. Exp. Med. 213, 123–138 (2016).
doi: 10.1084/jem.20150519
pubmed: 26694968
pmcid: 26694968
Gattinoni, L., Speiser, D. E., Lichterfeld, M. & Bonini, C. T memory stem cells in health and disease. Nat. Med. 23, 18–27 (2017).
doi: 10.1038/nm.4241
pubmed: 28060797
pmcid: 28060797
Crespo, J., Sun, H., Welling, T. H., Tian, Z. & Zou, W. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr. Opin. Immunol. 25, 214–221 (2013).
doi: 10.1016/j.coi.2012.12.003
pubmed: 23298609
pmcid: 23298609
Thimme, R. et al. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J. Virol. 79, 12112–12116 (2005).
doi: 10.1128/JVI.79.18.12112-12116.2005
pubmed: 16140789
pmcid: 16140789
Rosshart, S. et al. Interaction of KLRG1 with E-cadherin: new functional and structural insights. Eur. J. Immunol. 38, 3354–3364 (2008).
doi: 10.1002/eji.200838690
pubmed: 19009530
pmcid: 19009530
Kratchmarov, R., Magun, A. M. & Reiner, S. L. TCF1 expression marks self-renewing human CD8+ T cells. Blood Adv 2, 1685–1690 (2018).
doi: 10.1182/bloodadvances.2018016279
pubmed: 30021780
pmcid: 30021780
Snell, L. M. et al. CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity. Immunity 49, 678–694.e5 (2018).
doi: 10.1016/j.immuni.2018.08.002
pubmed: 30314757
pmcid: 30314757
Wang, Y. et al. The Transcription Factor TCF1 Preserves the Effector Function of Exhausted CD8 T Cells During Chronic Viral Infection. Front. Immunol. 10, 169 (2019).
doi: 10.3389/fimmu.2019.00169
pubmed: 30814995
pmcid: 30814995
Nagarsheth, N., Wicha, M. S. & Zou, W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat. Rev. Immunol. 17, 559–572 (2017).
doi: 10.1038/nri.2017.49
pubmed: 28555670
pmcid: 28555670
Taniuchi, I. CD4 Helper and CD8 Cytotoxic T Cell Differentiation. Annu. Rev. Immunol. 36, 579–601 (2018).
doi: 10.1146/annurev-immunol-042617-053411
pubmed: 29677476
pmcid: 29677476
Rothenberg, E. V. The chromatin landscape and transcription factors in T cell programming. Trends Immunol. 35, 195–204 (2014).
doi: 10.1016/j.it.2014.03.001
pubmed: 24703587
pmcid: 24703587
Wildt, K. F. et al. The transcription factor Zbtb7b promotes CD4 expression by antagonizing Runx-mediated activation of the CD4 silencer. J. Immunol. 179, 4405–4414 (2007).
doi: 10.4049/jimmunol.179.7.4405
pubmed: 17878336
pmcid: 17878336
Rui, J., Liu, H., Zhu, X., Cui, Y. & Liu, X. Epigenetic silencing of CD8 genes by ThPOK-mediated deacetylation during CD4 T cell differentiation. J. Immunol. 189, 1380–1390 (2012).
doi: 10.4049/jimmunol.1201077
pubmed: 22730529
pmcid: 22730529
Wang, L. et al. The zinc finger transcription factor Zbtb7b represses CD8-lineage gene expression in peripheral CD4+ T cells. Immunity 29, 876–887 (2008).
doi: 10.1016/j.immuni.2008.09.019
pubmed: 19062319
pmcid: 19062319
Vacchio, M. S. et al. A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4+ T cells. Nat. Immunol. 15, 947–956 (2014).
doi: 10.1038/ni.2960
pubmed: 25129370
pmcid: 25129370
Tsuchiya, Y. et al. ThPOK represses CXXC5, which induces methylation of histone H3 lysine 9 in Cd40lg promoter by association with SUV39H1: implications in repression of CD40L expression in CD8+ cytotoxic T cells. Journal of Leukocyte Biology 100, 327–338 (2016).
doi: 10.1189/jlb.1A0915-396RR
pubmed: 26896487
pmcid: 26896487
Setoguchi, R. et al. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319, 822–825 (2008).
doi: 10.1126/science.1151844
pubmed: 18258917
pmcid: 18258917
Cruz-Guilloty, F. et al. Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs. J. Exp. Med. 206, 51–59 (2009).
doi: 10.1084/jem.20081242
pubmed: 19139168
pmcid: 19139168
Reis, B. S., Rogoz, A., Costa-Pinto, F. A., Taniuchi, I. & Mucida, D. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4+ T cell immunity. Nat. Immunol. 14, 271–280 (2013).
doi: 10.1038/ni.2518
pubmed: 3804366
pmcid: 3804366
Lovatt, M. & Bijlmakers, M.-J. Stabilisation of β-Catenin Downstream of T Cell Receptor Signalling. PLOS ONE 5, e12794 (2010).
doi: 10.1371/journal.pone.0012794
pubmed: 20862283
pmcid: 20862283
Schenkel, J. M., Zloza, A., Li, W., Narasipura, S. D. & Al-Harthi, L. β-Catenin Signaling Mediates CD4 Expression on Mature CD8+ T Cells. J Immunol 185, 2013–2019 (2010).
doi: 10.4049/jimmunol.0902572
pubmed: 20631314
pmcid: 20631314
Ng, C. P. & Littman, D. R. Tcf1 and Lef1 pack their own HDAC. Nat. Immunol. 17, 615–616 (2016).
doi: 10.1038/ni.3469
pubmed: 27196513
pmcid: 27196513
Gervois, N. et al. High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells. Clin. Cancer Res. 6, 1459–1467 (2000).
pubmed: 10778978
pmcid: 10778978
Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004).
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
doi: 10.1093/nar/gkv007
pubmed: 4402510
pmcid: 4402510
Jeanmougin, M. et al. Should We Abandon the t-Test in the Analysis of Gene Expression Microarray Data: A Comparison of Variance Modeling Strategies. Plos one 5 (2010).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).
doi: 10.1073/pnas.0506580102
pubmed: 16199517
pmcid: 16199517
Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
doi: 10.1038/ng1180
pubmed: 12808457
pmcid: 12808457